The interaction of a RuIII(edta) complex (edta4− = ethylenediaminetetraacetate) with human apo-transferrin (apo-hTf) has been investigated using fluorescence spectroscopic techniques. The results of fluorescence spectral studies point towards static quenching involving binding of RuIII(edta) with apo-hTf. The value of the apparent binding constant (KA) estimated at physiological buffer is 4.72 × 104 M−1. Antiproliferative activity of RuIII(edta) in MCF-7 (breast carcinoma) cells was evidened by microculture tetrazolium test (MTT). Our results taken together are suggestive of the fact that the RuIII(edta) complex can bind to apo-hTf, and induce cell death by inhibiting NF-κB activation. The results of the computational based in silico analys...
Motivado pela perspectiva de complexos de rutênio podem ser utilizados no tratamento do câncer, o no...
The interaction of the anticancer Ru(iii) complex AziRu-in comparison with its analogue NAMI-A, curr...
Purpose: To investigate the antitumor activity of two newly synthesized ruthenium(III) [Ru(III)] com...
Ruthenium complexes are at the forefront of developments in metal-based anticancer drugs, but many q...
Interactions of anti-cancer Ru(III)-complexes, KP1019, KP418, and NAMI-A, with human serum transferr...
Ruthenium anti-cancer drugs are extensively studied as an alternative to platinum drugs that are wid...
The interaction of two ruthenium(III) complexes exhibiting high anticancer activity, namely trans-in...
NAMI-Ai.e.(ImH)[ trans -RuCl 4 (DMSO)(Im)](whereImisimidazole)isaruthenium(III)complexwithpromis...
Ruthenium(III) complexes have been described as the next generation of metal-based anticancer compou...
We report herein a systematic study on interactions of organometallic ruthenium(II) anticancer comp...
There is an increasing interest in the use of lanthanides in medicine. However, the mechanism of the...
We here describe a novel fluorescently-labelled Ru(III)-complex, prepared and tested in several cell...
There is an increasing interest in the use of lanthanides in medicine. However, the mechanism of the...
Among chemotherapeutic agents, cisplatin and the other platinum-based drugs have occupied for 35 yea...
Three coordination compounds of ruthenium(II), belonging to a recently synthesised series of water-s...
Motivado pela perspectiva de complexos de rutênio podem ser utilizados no tratamento do câncer, o no...
The interaction of the anticancer Ru(iii) complex AziRu-in comparison with its analogue NAMI-A, curr...
Purpose: To investigate the antitumor activity of two newly synthesized ruthenium(III) [Ru(III)] com...
Ruthenium complexes are at the forefront of developments in metal-based anticancer drugs, but many q...
Interactions of anti-cancer Ru(III)-complexes, KP1019, KP418, and NAMI-A, with human serum transferr...
Ruthenium anti-cancer drugs are extensively studied as an alternative to platinum drugs that are wid...
The interaction of two ruthenium(III) complexes exhibiting high anticancer activity, namely trans-in...
NAMI-Ai.e.(ImH)[ trans -RuCl 4 (DMSO)(Im)](whereImisimidazole)isaruthenium(III)complexwithpromis...
Ruthenium(III) complexes have been described as the next generation of metal-based anticancer compou...
We report herein a systematic study on interactions of organometallic ruthenium(II) anticancer comp...
There is an increasing interest in the use of lanthanides in medicine. However, the mechanism of the...
We here describe a novel fluorescently-labelled Ru(III)-complex, prepared and tested in several cell...
There is an increasing interest in the use of lanthanides in medicine. However, the mechanism of the...
Among chemotherapeutic agents, cisplatin and the other platinum-based drugs have occupied for 35 yea...
Three coordination compounds of ruthenium(II), belonging to a recently synthesised series of water-s...
Motivado pela perspectiva de complexos de rutênio podem ser utilizados no tratamento do câncer, o no...
The interaction of the anticancer Ru(iii) complex AziRu-in comparison with its analogue NAMI-A, curr...
Purpose: To investigate the antitumor activity of two newly synthesized ruthenium(III) [Ru(III)] com...